Key result
Prior metabolic syndrome in chronic heart failure is linked to hypertension, CAD, and elevated triglycerides.
Why the study?
Chronic heart failure carries high morbidity and mortality, particularly when combined with metabolic syndrome, warranting comparison of risk factors associated with progression to heart failure.
Are specific clinical risk factors differentially associated with the progression to chronic heart failure in patients with versus without metabolic syndrome?
Cohort (n=70)
Are specific clinical risk factors differentially associated with the progression to chronic heart failure in patients with versus without metabolic syndrome?
Answers are grounded in this paper and cite their sources.
Coronary heart disease and hypertension are strongly associated with the onset of chronic heart failure specifically in patients with pre-existing metabolic syndrome.
A BSTRACT Background: Chronic heart failure (CHF) is a multifaceted clinical condition that affects over huge number of individuals globally. Precise diagnosis and appropriate management are essential to prevent repeated hospital admissions, lower rates of illness and death, and enhance overall patient outcomes. Aims and Objectives: CHF is a significant medical problem, characterized by high morbidity and mortality, particularly when combined with metabolic syndrome (MS). We compared risk factors associated with the progression to HF in patients with or without with and without metabolic syndrome. Materials and Methods: During a follow-up of 3 months, 35 patients with prior MS and 35 patients without prior MS experienced CHF. Results: In our study, high blood pressure was found to be significantly associated with metabolic syndrome ( P = 0.0062). Patients with chronic heart failure and metabolic syndrome were more likely to have arterial hypertension compared to those without metabolic syndrome. Coronary artery disease was more strongly associated with CHF onset in patients with prior MS (all P for interactions <0.05). The triglyceride level in the MS group was significantly higher only in patients with prior MS (all P for interactions <0.05). Conclusion: The importance of clinical risk factors associated with CHF is dependent on whether the patient has had a prior MS. Coronary heart disease and hypertension are associated with CHF only in the presence of metabolic syndrome. Patients may benefit from early detection and correction of MS risk factors in CHF.
No takes yet. Share an insight, caveat, or question.
Rustamova et al. (2026) conducted a cohort in Chronic Heart Failure and Metabolic Syndrome (n=70). Prior metabolic syndrome vs. No prior metabolic syndrome was evaluated on Risk factors associated with progression to heart failure (e.g., high blood pressure) (p=0.0062). In patients with chronic heart failure, prior metabolic syndrome was associated with high blood pressure, coronary artery disease, and higher triglyceride levels.
Synapse has enriched 10 related papers. Consider them for comparative context: